Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review
2018 ◽
Vol 106
◽
pp. 956-965
◽
2013 ◽
Vol 1
(1)
◽
pp. 65-74
◽
2014 ◽
Vol 10
(1)
◽
pp. 24
◽
2004 ◽
Vol 116
(5)
◽
pp. 338-344
◽
2013 ◽
Vol 24
(4)
◽
pp. 40